Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

0 avis

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Archive ouverte

Edité par CCSD ; American Society of Hematology -

International audience. Key Points In adult ALL, oncogenetic markers and minimal residual disease levels are independent outcome predictors. Both factors should be used for individual treatment stratification.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study

Archive ouverte | Huguet, Françoise | CCSD

International audience. Purpose Retrospective comparisons have suggested that adolescents or teenagers with acute lymphoblastic leukemia (ALL) benefit from pediatric rather than adult chemotherapy regimens. Thus, th...

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

Archive ouverte | Ben Abdelali, Raouf | CCSD

International audience. Despite recent progress in the understanding of acute lymphoblastic leukemia (T-ALL) oncogenesis, few markers are sufficiently frequent in large subgroups to allow their use in therapeutic st...

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial

Archive ouverte | Huguet, Francoise | CCSD

International audience. Purpose To evaluate randomly the role of hyperfractionated cyclophosphamide (hyper-C) dose intensification in adults with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic ...

Chargement des enrichissements...